We determined MMP using 5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolylcarbocyanine iodide (JC-1)
Epigenetic regulation of the stem cell mitogen Fgf-2 by Mbd1 in adult neural stem/progenitor cells
Disappointing GLP-1 Results in Alzheimers Trial: Underscores Promise (and Limits) of Single-Agent Approaches Key takeaways Two large Phase 3 trials (EVOKE and EVOKE+) of oral semaglutide (a GLP1 receptor agonist) in early Alzheimers disease showed no significant slowing of cognitive or functional decline vs
Traditional AI models require extensive retraining to update their knowledge, which can be resource-intensive
May 2026 : Some patients who took Zepbound developed a condition (NAION) that caused them to experience sudden, painless, and irreversible blindness, and they allege there is an association
The Verdict: Limited and preliminary